Thiosemicarbazide Derivatives as Urease Inhibitors
sequences in Staphylococcus carnosus and contribution
of the enzyme to virulence. Infect Immun;57:2998–3002.
8. Johnson D.E., Russell R.G., Lockatell C.V., Zulty
J.C., Warren J.W., Mobley H.L. (1993) Contribution of
Proteus mirabilis urease to persistence, urolithiasis,
23. Hanif M., Shoaib K., Saleem M., Hasan Rama N.,
Zaib S., Iqbal J. (2012) Synthesis, urease inhibition,
antioxidant, antibacterial, and molecular docking stud-
ies of 1,3,4-Oxadiazole derivatives. ISRN Pharmacol;
2012:9.
and acute pyelonephritis in
ascending urinary tract infection. Infect Im-
mun;61:2748–2754.
a
mouse model of
24. Du X., Guo C., Hansell E., Doyle P.S., Caffrey C.R.,
Holler T.P., McKerrow J.H., Cohen F.E. (2002)
Synthesis and structure–activity relationship study of
potent trypanocidal thio semicarbazone inhibitors of
the trypanosomal cysteine protease cruzain. J Med
Chem;45:2695–2707.
25. Yuan J., Lovejoy D.B., Richardson D.R. (2004) Novel
di-2-pyridyl–derived iron chelators with marked and
selective antitumor activity: in vitro and in vivo assess-
ment. Blood;104:1450–1458.
9. Jones B.D., Lockatell C.V., Johnson D.E., Warren
J.W., Mobley H.L. (1990) Construction of a urease-
negative mutant of Proteus mirabilis: analysis of viru-
lence in a mouse model of ascending urinary tract
infection. Infect Immun;58:1120–1123.
10. Sabbaj J., Sutter V., Finegold S. (1970) Urease and
deaminase activities of fecal bacteria in hepatic coma.
Antimicrob Agents Chemother;10:181–185.
26. Aboul-Fadl T., Bin-Jubair F.A. (2010) Anti-tubercular
11. Samtoy B., DeBeukelaer M.M. (1980) Ammonia
encephalopathy secondary to urinary tract infection
with Proteus mirabilis. Pediatrics;65:294–297.
12. Sahrawat K.L. (1980) Control of urea hydrolysis and
nitrification in soil by chemicals—Prospects and prob-
lems. Plant Soil;57:335–352.
activity of isatin derivatives. Int
Sci;1:113–126.
27. Banerjee D., Yogeeswari P., Bhat P., Thomas A., Srividya
M., Sriram D. (2011) Novel isatinyl thiosemicarbazones
derivatives as potential molecule to combat HIV-TB
co-infection. Eur J Med Chem;46:106–121.
J
Res Pharm
13. Bremner J., Douglas L. (1971) Inhibition of urease
activity in soils. Soil Biol Biochem;3:297–307.
14. Pearson R., Smith J. (1943) The utilization of urea in
the bovine rumen. 2. The conversion of urea to ammo-
nia. Biochem J;37:148–153.
28. Chen L.-R., Wang Y.-C., Lin Y.W., Chou S.-Y., Chen
S.-F., Liu L.T., Wu Y.T., Kuo C.J., Chen T.S., Juang
S.H. (2005) Synthesis and evaluation of isatin deriva-
tives as effective SARS coronavirus 3CL protease
inhibitors. Bioorg Med Chem Lett;15:3058–3062.
15. Saboury A.A., Moosavi-movahedi A.A. (1997) A simple
novel method for studying the combined inhibitory
effects of ethylurea and N, N-Dimethylurea on jack
bean urease. J Enzyme Inhib Med Chem;11:217–222.
16. Fishbein W.N., Carbone P.P. (1965) Urease Catalysis:
II. Inhibition of the enzyme by hydroxyurea, hydroxyl-
29. Chiyanzu I., Clarkson C., Smith P.J., Lehman J., Gut
J., Rosenthal P.J., Chibale K. (2005) Design, synthesis
and anti-plasmodial evaluation in vitro of new 4-amino-
quinoline
isatin
derivatives.
Bioorg
Med
Chem;13:3249–3261.
30. Pandeya S.N., Smitha S., Jyoti M., Sridhar S.K. (2005)
Biological activities of isatin and its derivatives. Acta
pharm;55:27–46.
amine,
and
acetohydroxamic
acid.
J
Biol
Chem;240:2407–2414.
17. Todd M.J., Hausinger R.P. (1989) Competitive inhibi-
tors of Klebsiella aerogenes urease. Mechanisms of
31. Patel A., Bari S., Talele G., Patel J., Sarangapani M.
(2010) Synthesis and antimicrobial activity of some
new isatin derivatives. Iran J Pharm Res;5:249–254.
32. Da Silva J.F.M., Garden S.J., Pinto A.C. (2001) The
chemistry of isatins: a review from 1975 to 1999. J
Braz Chem Soc;12:273–324.
33. Singh U., Pandeya S., Singh A., Srivastava B., Pandey
M. (2010) Synthesis and antimicrobial activity of
Schiff’s and N-Mannich bases of isatin and its deriva-
tives with 4-amino-N-carbamimidoyl benzene sulfon-
amide. Int J Pharm Sci Drug Res;2:151–154.
interaction with the nickel active site.
J
Biol
Chem;264:15835–15842.
18. McCarthy G., Bremner J., Lee J. (1990) Inhibition of
plant and microbial ureases by phosphoramides. Plant
Soil;127:269–283.
19. Ibrar A., Khan I., Abbas N. (2013) Structurally diversi-
fied heterocycles and related privileged scaffolds as
potential urease inhibitors:
a brief overview. Arch
Pharm;346:423–446.
20. Kosikowska P., Berlicki L. (2011) Urease inhibitors as
potential drugs for gastric and urinary tract infections:
a patent review. Expert Opin Ther Pat;21:945–957.
21. Amtul Z., Rahman A.U., Siddiqui R.A., Choudhary M.I.
(2002) Chemistry and mechanism of urease inhibition.
Curr Med Chem;9:1323–1348.
22. Aslam M.A.S., Mahmood S.-U., Shahid M., Saeed A.,
Iqbal J. (2011) Synthesis, biological assay in vitro and
molecular docking studies of new Schiff base deriva-
34. Vine K.L., Matesic L., Locke J.M., Ranson M., Skro-
peta D. (2009) Cytotoxic and anticancer activities of
isatin and its derivatives: a comprehensive review from
2000-2008. Anti-Cancer Agents Med Chem (Formerly
Current Medicinal Chemistry;9:397–414.
35. Xiao Z.P., Peng Z.Y., Dong J.J., Deng R.C., Wang
X.D., Ouyang H., Yang P., He J., Wang Y.F., Zhu M.,
Peng X.C., Peng W.X., Zhu H.L. (2013) Synthesis,
molecular docking and kinetic properties of b-hydroxy-
b-phenylpropionyl-hydroxamic acids as Helicobacter
pylori urease inhibitors. Eur J Med Chem;68:212–221.
tives as potential urease inhibitors. Eur
J Med
Chem;46:5473–5479.
Chem Biol Drug Des 2014
5